Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 6 | 2022 | 176 | 2.150 |
Why?
|
| Lung Diseases | 6 | 2025 | 401 | 1.670 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | 2022 | 26 | 1.520 |
Why?
|
| Granulomatosis with Polyangiitis | 4 | 2022 | 39 | 1.210 |
Why?
|
| Churg-Strauss Syndrome | 3 | 2022 | 20 | 1.060 |
Why?
|
| Lung | 7 | 2024 | 1566 | 1.060 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 233 | 0.870 |
Why?
|
| Cough | 2 | 2023 | 99 | 0.840 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 580 | 0.780 |
Why?
|
| Immune System Diseases | 1 | 2022 | 52 | 0.730 |
Why?
|
| Hemoptysis | 1 | 2021 | 22 | 0.700 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2021 | 21 | 0.690 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2022 | 210 | 0.660 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2020 | 28 | 0.640 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 159 | 0.630 |
Why?
|
| Connective Tissue Diseases | 1 | 2019 | 32 | 0.610 |
Why?
|
| Pulmonary Medicine | 1 | 2019 | 32 | 0.600 |
Why?
|
| Hemorrhage | 2 | 2023 | 498 | 0.570 |
Why?
|
| Pneumonia | 1 | 2022 | 344 | 0.570 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2021 | 214 | 0.550 |
Why?
|
| Rheumatology | 1 | 2019 | 128 | 0.540 |
Why?
|
| Pyrazoles | 1 | 2020 | 359 | 0.530 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 463 | 0.480 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2025 | 1263 | 0.450 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 6 | 0.430 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 32 | 0.420 |
Why?
|
| Gain of Function Mutation | 3 | 2022 | 115 | 0.370 |
Why?
|
| Status Epilepticus | 1 | 2014 | 157 | 0.370 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 195 | 0.370 |
Why?
|
| Mutation | 3 | 2024 | 6194 | 0.350 |
Why?
|
| Microscopic Polyangiitis | 2 | 2021 | 14 | 0.350 |
Why?
|
| Child | 13 | 2025 | 26316 | 0.330 |
Why?
|
| Child, Preschool | 9 | 2025 | 15057 | 0.280 |
Why?
|
| Kidney Diseases | 2 | 2023 | 482 | 0.270 |
Why?
|
| Cohort Studies | 3 | 2022 | 5122 | 0.270 |
Why?
|
| Infant | 7 | 2025 | 13324 | 0.240 |
Why?
|
| Coatomer Protein | 2 | 2023 | 29 | 0.230 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2022 | 675 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 2122 | 0.220 |
Why?
|
| Humans | 21 | 2025 | 131782 | 0.220 |
Why?
|
| Dyspnea | 2 | 2023 | 160 | 0.210 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 2022 | 40 | 0.210 |
Why?
|
| Pleural Effusion | 1 | 2023 | 106 | 0.190 |
Why?
|
| Lymphadenopathy | 1 | 2023 | 32 | 0.190 |
Why?
|
| Glomerulonephritis | 1 | 2023 | 75 | 0.190 |
Why?
|
| Arthritis | 1 | 2023 | 85 | 0.190 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 55 | 0.180 |
Why?
|
| Hematuria | 1 | 2022 | 48 | 0.180 |
Why?
|
| Myeloblastin | 1 | 2021 | 18 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 589 | 0.180 |
Why?
|
| Male | 11 | 2025 | 65291 | 0.180 |
Why?
|
| Autoimmunity | 1 | 2022 | 182 | 0.170 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 9 | 0.170 |
Why?
|
| Myositis | 1 | 2022 | 106 | 0.170 |
Why?
|
| Peroxidase | 1 | 2021 | 64 | 0.170 |
Why?
|
| Filamins | 1 | 2021 | 26 | 0.170 |
Why?
|
| Biopsy | 2 | 2024 | 1252 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2022 | 359 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 209 | 0.160 |
Why?
|
| France | 1 | 2020 | 89 | 0.160 |
Why?
|
| Respiratory System Abnormalities | 1 | 2021 | 45 | 0.160 |
Why?
|
| Female | 12 | 2025 | 71223 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 139 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17667 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 275 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2021 | 466 | 0.140 |
Why?
|
| Recurrence | 1 | 2021 | 1483 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 312 | 0.130 |
Why?
|
| Adolescent | 7 | 2025 | 20994 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2483 | 0.110 |
Why?
|
| Disease Progression | 1 | 2021 | 2221 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 364 | 0.100 |
Why?
|
| Texas | 1 | 2020 | 3622 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8597 | 0.080 |
Why?
|
| Syndrome | 2 | 2023 | 1170 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 354 | 0.070 |
Why?
|
| Graft vs Host Disease | 2 | 2024 | 680 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12997 | 0.070 |
Why?
|
| Adult | 3 | 2025 | 31710 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2963 | 0.060 |
Why?
|
| Registries | 2 | 2022 | 1598 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2025 | 225 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2024 | 159 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5297 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 119 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 189 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 416 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 10102 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 28897 | 0.040 |
Why?
|
| Survival Rate | 1 | 2025 | 2151 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 301 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2695 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1912 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4953 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6509 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3349 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10965 | 0.010 |
Why?
|